
|Articles|September 27, 2006
Idenix Names Weidenbruch General Counsel
Author(s)BioPharm International Editors
Idenix Pharmaceuticals, Inc. (Cambridge, MA, www.idenix.com) has appointed John F. Weidenbruch to the position of executive vice president and general counsel.
Advertisement
Idenix Pharmaceuticals, Inc. (Cambridge, MA,
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
2
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
3
Biocapacitance as a PAT Tool: Real-Time Biomass Monitoring for Upstream Bioprocessing
4
How Engineered Exosomes Can Impact Targeted Therapies
5





